UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

PATH is shifting automation to agentic AI, turning orchestration into operating leverage that deepens adoption, boosts ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...

UiPath will partner with Nvidia to strengthen customer workflows with generative AI. The company is also collaborating with OpenAI and Snowflake to improve agentic automation. Today's announcements ...

UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...

We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...

UiPath Chief Marketing Officer Michael Atalla argues that enterprises aren’t moving toward agent-only automation, but toward ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...